Damora Therapeutics Earnings
NASDAQ: DMRAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Thu, Nov 5, 2026
Fiscal period
Sep/2026
EPS estimate
$-0.52
Damora Therapeutics earnings summary
Damora Therapeutics is scheduled to report Sep/2026 earnings on Nov 5, 2026, with analysts expecting EPS of $-0.52. In its most recent report on Aug 10, 2026 (Q2 2026), DMRA posted EPS of $-0.39. Across the last 16 reports, DMRA shares moved an average of 37.8% (in either direction) in the first trading session after results, rising 7 times and falling 8 times.
Summary generated from market data by MetaCap's automated system. Methodology
DMRA earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 10, 2026 | — | $-0.39 | — | -0.7% |
| May 12, 2026 | — | $-0.62 | — | +2.8% |
| Mar 10, 2026 | — | $10.86 | — | -31.1% |
| Nov 6, 2025 | — | $-2.36 | — | +442.0% |
| Aug 5, 2025 | — | $-2.60 | — | 0.0% |
| May 8, 2025 | — | $-1.92 | — | +4.9% |
| Mar 19, 2025 | — | $-5.17 | — | -43.9% |
| Nov 1, 2024 | — | $-3.39 | — | +5.0% |
| Aug 12, 2024 | — | $-4.92 | — | -6.9% |
| Apr 29, 2024 | — | $-5.05 | — | -2.9% |
| Mar 8, 2024 | — | $-27.66 | — | -6.0% |
| Nov 6, 2023 | — | $-7.50 | — | +5.5% |
| Jul 31, 2023 | — | $-0.41 | — | -7.1% |
| Apr 28, 2023 | — | $-0.51 | — | +21.9% |
| Mar 9, 2023 | — | $-0.55 | — | +12.9% |
| Nov 8, 2022 | — | $-0.54 | — | -11.5% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.